Here begins the text.



 The Medical Device Single Audit Program (MDSAP) is intended to allow MDSAP Auditing Organizations to conduct a single audit of a medical device manufacturer that will satisfy the relevant requirements of the medical device regulatory authorities participating in the program.

 Japan's Ministry of Health, Labour and Welfare, and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has been participating to the program since June 2015.

 International partners that are participating in the MDSAP include:

  • Therapeutic Goods Administration of Australia,
  • Brazil's Agência Nacional de Vigilância Sanitária,
  • Health Canada, and
  • U.S. Food and Drug Administration.
  • The World Health Organization (WHO) Prequalification of In Vitro Diagnostics (IVDs) Programme and the European Union (EU) are Official Observers

Acceptance of MDSAP Audit Reports

 MDSAP audit reports may be used as a way to demonstrate conformance to Japanese medical device QMS requirements (see details).
 PMDA has been accepting MDSAP audit reports since 2016. The following chart illustrates the results of the acceptance from 2017 to 2019.

PMDA acceptance of MDSAP audit reports from FY2017 to FY2019

 Stakeholders in Japan are discussing in order to formalize these acceptance activities. The discussion is planned to be completed by the end of March 2022.


JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

  • Contact us
  • Access/Map

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.